Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion

Leone, Robert D., Zhao, Liang, Englert, Judson M., Sun, Im-Meng, Oh, Min-Hee, Sun, Im-Hong, Arwood, Matthew L., Bettencourt, Ian A. +9 more·2019·Science

DOI 10.1126/science.aav2588

Cited by (1,001)

Items 101–200 of 1,001

The role of RNA methylation in tumor immunity and its potential in immunotherapy
Yan Li, Haoer Jin, Qingling Li, Liangrong Shi, Yitao Mao, Luqing Zhao · 2024 · Molecular Cancer
The adaptive transition of glioblastoma stem cells and its implications on treatments
Zeyu Wang, Hao Zhang, Shengchao Xu, Zhixiong Liu, Quan Cheng · 2021 · Signal Transduction and Targeted Therapy
Mitochondrial Metabolism Regulation of T Cell–Mediated Immunity
Elizabeth M. Steinert, Karthik Vasan, Navdeep S. Chandel · 2021 · Annual Review of Immunology
KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance
Anastasia‐Maria Zavitsanou, Ray Pillai, Hao Yuan, Warren Wu, Eric Bartnicki, Triantafyllia R. Karakousi, Sahith Rajalingam, Alberto M. Herrera, Angeliki Karatza, Ali Rashidfarrokhi et al. · 2023 · Cell Reports
Unlocking the full potential of memory T cells in adoptive T cell therapy for hematologic malignancies
Ding-Ya Sun, Yi-Jie Hu, Xin Li, Jun Peng, Zhijie Dai, Shan Wang · 2024 · International Immunopharmacology
Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis
Jiang Yu, Qiuju Han, Huajun Zhao, Jian Zhang · 2021 · Journal of Experimental & Clinical Cancer Research
Fundamentals of T Cell Metabolism and Strategies to Enhance Cancer Immunotherapy
Guillermo O. Rangel Rivera, Hannah M. Knochelmann, Connor J. Dwyer, Aubrey S. Smith, Megan M. Wyatt, Amalia M. Rivera-Reyes, Jessica E. Thaxton, Chrystal Mary Paulos · 2021 · Frontiers in Immunology
Clinical development of metabolic inhibitors for oncology
Kathryn M. Lemberg, Sadakatali S. Gori, Takashi Tsukamoto, Rana Rais, Barbara S. Slusher · 2022 · Journal of Clinical Investigation
Cancer metabolism and carcinogenesis
Jianqiang Yang, Chloe Shay, Nabil F. Saba, Yong Teng · 2024 · Experimental Hematology and Oncology
Recent advances in metabolomics analysis for early drug development.
Juan Carlos Alarcon-Barrera, S. Kostidis, Alejandro Ondo-Méndez, M. Giera · 2022 · Drug Discovery Today
The Complex Integration of T-cell Metabolism and Immunotherapy
Matthew Z. Madden, Jeffrey C. Rathmell · 2021 · Cancer Discovery
T cell dysfunction and therapeutic intervention in cancer
Caitlin C. Zebley, Dietmar Zehn, Stephen M Gottschalk, Hongbo Chi · 2024 · Nature Immunology
Cancer metabolism and tumor microenvironment: fostering each other?
Yiyuan Yuan, Huimin Li, Pu Wang, Leilei Chen, Dong Sheng Guo, Hongfei Jiang, Bo He, Siyuan Qin, Kui Wang, Na Li et al. · 2021 · Science China Life Sciences
Control of immunity via nutritional interventions
Nicholas Collins, Yasmine Belkaid · 2022 · Immunity
Targeting pancreatic cancer metabolic dependencies through glutamine antagonism
Joel Encarnación-Rosado, Albert S.W. Sohn, Douglas E. Biancur, Elaine Y. Lin, Victoria Osorio-Vasquez, Tori C. Rodrick, Diana González-Baerga, Ende Zhao, Yumi Yokoyama, Diane M. Simeone et al. · 2023 · Nature Cancer
Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes
Ligon, John A, Choi, Woonyoung, Cojocaru, Gady, Fu, Wei, Hsiue, Emily Han-Chung, Oke, Teniola F, Siegel, Nicholas, Fong, Megan H, Ladle, Brian, Pratilas, Christine A et al. · 2021 · Journal for ImmunoTherapy of Cancer
The therapeutic implications of immunosuppressive tumor aerobic glycolysis
Bradley I. Reinfeld, W. Kimryn Rathmell, Tae Kon Kim, Jeffrey C. Rathmell · 2021 · Cellular and Molecular Immunology
Histone lactylation inhibits RARγ expression in macrophages to promote colorectal tumorigenesis through activation of TRAF6-IL-6-STAT3 signaling
Xiu‐Ming Li, Yun Yang, Fuquan Jiang, Guang Hu, Shan Wan, Wenying Yan, Xiao‐Shun He, Fei Xiao, Xuemei Yang, Xin Guo et al. · 2024 · Cell Reports
Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug
Rana Rais, Kathryn M. Lemberg, Lukáš Tenora, Matthew L. Arwood, Arindom Pal, Jesse Alt, Ying Wu, Jenny Lam, Joanna Marie H. Aguilar, Liang Zhao et al. · 2022 · Science Advances
Acetate acts as a metabolic immunomodulator by bolstering T-cell effector function and potentiating antitumor immunity in breast cancer
Katelyn D. Miller, Seamus O’Connor, Katherine A. Pniewski, Toshitha Kannan, Reyes Acosta, Gauri Mirji, Sara B. Papp, Michael Hulse, Dzmitry Mukha, Sabina I. Hlavaty et al. · 2023 · Nature Cancer
Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma
Shuai Wu, Takeshi Fukumoto, Jianhuang Lin, Timothy Nacarelli, Yemin Wang, Dionzie Ong, Heng Liu, Nail Fatkhutdinov, Joseph A. Zundell, Sergey V. Karakashev et al. · 2021 · Nature Cancer
Evolutionary metabolic landscape from preneoplasia to invasive lung adenocarcinoma
Meng Nie, Ke Yao, Xinsheng Zhu, Na Chen, Nan Xiao, Yi Wang, Bo Peng, LiAng Yao, Peng Li, Peng Zhang et al. · 2021 · Nature Communications
A glutamine tug-of-war between cancer and immune cells: recent advances in unraveling the ongoing battle
Bolin Wang, J. Pei, Sheng-Nan Xu, Jie Liu, Jin-Ming Yu · 2024 · Journal of experimental & clinical cancer research : CR
Metabolic crosstalk in the tumor microenvironment regulates antitumor immunosuppression and immunotherapy resisitance
Fang Wei, Dan Wang, Junyuan Wei, Niwen Tang, Le Min Tang, Fang Xiong, Can Jie Guo, Ming Zhou, Xiaoling Li, Guiyuan Li et al. · 2020 · Cellular and Molecular Life Sciences
On the Origin of ATP Synthesis in Cancer
T. Seyfried, G. Arismendi-Morillo, P. Mukherjee, C. Chinopoulos · 2020 · iScience
Beyond the Barrier: Unraveling the Mechanisms of Immunotherapy Resistance
Hannah Noelle Bell, Weiping Zou · 2024 · Annual Review of Immunology
The hexosamine biosynthetic pathway and cancer: Current knowledge and future therapeutic strategies
Christine Lam, Jin‐Yih Low, Phuoc Tho Tran, Hailun Wang · 2021 · Cancer Letters
Ammonia-induced lysosomal and mitochondrial damage causes cell death of effector CD8+ T cells
Huafeng Zhang, Jincheng Liu, Wu Yuan, Qian Zhang, Xiao Ling Luo, Yonggang Li, Yue’e Peng, Jingyu Feng, Xiaoyu Liu, Jie Chen et al. · 2024 · Nature Cell Biology
Microenvironmental influences on T cell immunity in cancer and inflammation
Darren R. Heintzman, Emilie L. Fisher, Jeffrey C. Rathmell · 2022 · Cellular and Molecular Immunology
Tumor-associated macrophages are shaped by intratumoral high potassium via Kir2.1
Sheng Chen, Wenyu Cui, Zhexu Chi, Qian Xiao, Tianyi Hu, Qizhen Ye, Kaixiang Zhu, Weiwei Yu, Zhen Wang, Chengxuan Yu et al. · 2022 · Cell Metabolism
Metabolic control of CD47 expression through LAT2-mediated amino acid uptake promotes tumor immune evasion
Zenan Wang, Binghao Li, Shan Li, Wenlong Lin, Zhan Wang, Shengdong Wang, Weida Chen, Wei Shi, Tao Chen, Hao Zhou et al. · 2022 · Nature Communications
Leucine-tRNA-synthetase-2-expressing B cells contribute to colorectal cancer immunoevasion
Zhiqiang Wang, Lu Zhou, Shengli Lin, Jie Xia, Ziwen Zhong, Zhangjuan Xie, Yun Xing, Jingbo Qie, Mengxia Jiao, Yifan Li et al. · 2022 · Immunity
Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy
Xin Lian, Kailin Yang, Renliang Li, Maomao Li, Jing Zuo, Bohao Zheng, Wei Wang, Ping Wang, Shengtao Zhou · 2022 · Molecular Cancer
Integration of transcriptomics, proteomics, and metabolomics data to reveal HER2-associated metabolic heterogeneity in gastric cancer with response to immunotherapy and neoadjuvant chemotherapy
Qihang Yuan, Dawei Deng, Pan Chen, Jie Ren, Tianfu Wei, Zeming Wu, Biao Zhang, Shuang Li, Peiyuan Yin, Dong Shang · 2022 · Frontiers in Immunology
Lactate is an epigenetic metabolite that drives survival in model systems of glioblastoma
Consuelo Torrini, Trang Thi Thu Nguyen, Chang Shu, Angeliki Mela, Nelson Humala, Aayushi Mahajan, E. Seeley, Guoan Zhang, Mike‐Andrew Westhoff, Georg Karpel‐Massler et al. · 2022 · Molecular Cell
Glutamine metabolic microenvironment drives M2 macrophage polarization to mediate trastuzumab resistance in HER2‐positive gastric cancer
Xingbin Hu, Zhenfeng Ma, Beibei Xu, Shulong Li, Zhiqi Yao, Bishan Liang, Jiao Wang, Wangjun Liao, Lin Li, Chunling Wang et al. · 2023 · 癌症：英文版
Loss‐of‐Function Genetic Screening Identifies Aldolase A as an Essential Driver for Liver Cancer Cell Growth Under Hypoxia
Niu, Yi, Lin, Ziyou, Wan, Arabella, Sun, Lei, Yan, Shijia, Liang, Heng, Zhan, Siyue, Chen, Dongshi, Bu, Xianzhang, Liu, Peiqing et al. · 2021 · Hepatology
Polyamines drive myeloid cell survival by buffering intracellular pH to promote immunosuppression in glioblastoma
Jason M. Miska, Aida Rashidi, Catalina Lee-Chang, Peng Gao, Aurora Lopez‐Rosas, Peng Zhang, Rachel A. Burga, Brandyn A. Castro, Ting Xiao, Yu Han et al. · 2021 · Science Advances
Metabolic Reprogramming in Anticancer Drug Resistance: A Focus on Amino Acids
Erica Pranzini, Elisa Pardella, Paolo Paoli, Sarah‐Maria Fendt, Maria Letizia Taddei · 2021 · Trends in cancer
Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy
Kun Huang, Ying Han, Yihong Chen, Hong Shen, Shan Zeng, Changjing Cai · 2025 · Molecular Cancer
Cancer cell metabolic reprogramming: a keystone for the response to immunotherapy
Michaël Cerezo, Stéphane Rocchi · 2020 · Cell Death and Disease
Mitochondrial metabolism-mediated redox regulation in cancer progression
Austin C. Boese, Sumin Kang · 2021 · Redox Biology
Asparagine restriction enhances CD8+ T cell metabolic fitness and antitumoral functionality through an NRF2-dependent stress response
JN Rashida Gnanaprakasam, Bhavana Kushwaha, Lingling Liu, Xuyong Chen, Siwen Kang, Tingting Wang, Teresa Cassel, Christopher M. Adams, Richard M. Higashi, David A. Scott et al. · 2023 · Nature Metabolism
Metabolic Reprogramming of Immune Cells in the Tumor Microenvironment
Jing Wang, Yuanli He, Feiming Hu, Chenchen Hu, Yuanjie Sun, Kun Yang, Shuya Yang · 2024 · International Journal of Molecular Sciences
Beggars banquet: Metabolism in the tumor immune microenvironment and cancer therapy
Weiping Zou, Douglas R. Green · 2023 · Cell Metabolism
Metabolic interplays between the tumour and the host shape the tumour macroenvironment
Patricia Altea‐Manzano, Amanda R. Decker-Farrell, Tobias Janowitz, Ayelet Erez · 2025 · Nature reviews. Cancer
Immunomodulatory potential of natural products from herbal medicines as immune checkpoints inhibitors: Helping to fight against cancer via multiple targets
Zhangfeng Zhong, Chi Teng Vong, Feiyu Chen, Horyue Tan, Cheng Zhang, Ning Wang, Liao Cui, Yitao Wang, Yibin Feng · 2022 · Medicinal Research Reviews
Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer
Lin Zhao, Yuanyuan Liu, Simiao Zhang, Lingyu Wei, Hongbing Cheng, Jinsheng Wang, Jia Wang · 2022 · Cell Death and Disease
Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment
Yifei Zhu, Xinyan Li, Lei Wang, Xiwei Hong, Jie Yang · 2022 · Frontiers in Endocrinology
Impairing Tumor Metabolic Plasticity via a Stable Metal‐Phenolic‐Based Polymeric Nanomedicine to Suppress Colorectal Cancer
Xiaoling Li, Zhenyu Duan, Xiaoting Chen, Dayi Pan, Qiang Luo, Lei Gu, Gang Xu, Yinggang Li, Hu Zhang, Qiyong Gong et al. · 2023 · Advanced Materials
m6A methylation: a process reshaping the tumour immune microenvironment and regulating immune evasion
Xiaoxue Cao, Qishun Geng, Danping Fan, Qiong Wang, Xing Wang, Mengxiao Zhang, Lu Zhao, Yi Jiao, Tingting Deng, Honglin Liu et al. · 2023 · Molecular Cancer
CTLs heterogeneity and plasticity: implications for cancer immunotherapy
Shengkun Peng, Anqi Lin, Aimin Jiang, Cangang Zhang, Jian Zhang, Quan Cheng, Peng Luo, Yifeng Bai · 2024 · Molecular Cancer
Aurora kinase A inhibition reverses the Warburg effect and elicits unique metabolic vulnerabilities in glioblastoma
Trang Thi Thu Nguyen, Enyuan Shang, Chang Shu, Sung Soo Kim, Angeliki Mela, Nelson Humala, Aayushi Mahajan, Hee Won Yang, Hasan Orhan Akman, Catarina Maria Quinzii et al. · 2021 · Nature Communications
Amino Acid Metabolism in Cancer Drug Resistance
Hee-Chan Yoo, Jung Min Han · 2022 · Cells
Alterations in PD-L1 succinylation shape anti-tumor immune responses in melanoma
Long Liang, Xinwei Kuang, Yi He, Lin Zhu, Poyee Lau, Xin Li, Dingan Luo, Lan Gong, Wenbin Zhou, Fanglin Zhang et al. · 2025 · Nature Genetics
RETRACTED ARTICLE: Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancer
Alok Kumar Singh, Monali Praharaj, Kara A. Lombardo, Takahiro Yoshida, Andrés Matoso, Alex S. Baras, Liang Zhao, Geetha Srikrishna, Joy Huang, Pankaj Prasad et al. · 2022 · Nature Communications · Retracted
Lactate: The Mediator of Metabolism and Immunosuppression
Yuanyuan Zhang, Zhao Zhai, Jiali Duan, Xiangcai Wang, Jinghua Zhong, Longqiu Wu, An Li, Miao Cao, Yanyang Wu, Huaqiu Shi et al. · 2022 · Frontiers in Endocrinology
Discovery of IPN60090, a Clinical Stage Selective Glutaminase‑1 (GLS-1) Inhibitor with Excellent Pharmacokinetic and Physicochemical Properties
Michael Soth, Kang Le, Maria Emilia Di Francesco, Matthew M. Hamilton, Gang Liu, Jason P. Burke, Christopher L. Carroll, Jeffrey J. Kovacs, Jennifer Bardenhagen, Christopher Aaron Bristow et al. · 2020 · Journal of Medicinal Chemistry
Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer
Karan Mediratta, Sara El‐Sahli, Vanessa M. D’Costa, Lisheng Wang · 2020 · Cancers
Glutamine Antagonist Synergizes with Electrodynamic Therapy to Induce Tumor Regression and Systemic Antitumor Immunity
Gui Chen, Qing Xu, Zhenzhen Feng, Qinqin Xu, Xuhui Zhang, Yuanyuan Yang, Yuxuan Zhang, Xing‐Jie Liang, Zhiqiang Yu, Meng Yu · 2022 · ACS Nano
Non-Small-Cell Lung Cancer Signaling Pathways, Metabolism, and PD-1/PD-L1 Antibodies
Mariacarmela Santarpía, Andrés Aguilar, Imane CHAIB-OUKADOUR, Andrés Felipe Cardona, Sara Fancelli, Fernando Laguía, Jillian Wilhelmina Paulina Bracht, Peng Cao, Miguel Ángel Molina‐Vila, Niki Karachaliou et al. · 2020 · Cancers
Targeting glutamine metabolism slows soft tissue sarcoma growth
Pearl Lee, Dania M. Malik, Nicholas R. Perkons, Peiwei Huangyang, Sanika Khare, Seth D. Rhoades, Yao-Yu Gong, Michelle Burrows, Jennifer M. Finan, Itzhak Nissim et al. · 2020 · Nature Communications
Metabolism and polarization regulation of macrophages in the tumor microenvironment
Jia Wang, Shichao Mi, Muyao Ding, Xue Li, Shengtao Yuan · 2022 · Cancer Letters
Pharmacologic LDH inhibition redirects intratumoral glucose uptake and improves antitumor immunity in solid tumor models
Svena Verma, Sadna Budhu, Inna S. Serganova, Lauren Dong, Levi Mark B Mangarin, Jonathan F. Khan, Mamadou A. Bah, Anaïs Assouvie, Yacine Marouf, Isabell Schulze et al. · 2024 · Journal of Clinical Investigation
CD28 costimulation drives tumor-infiltrating T cell glycolysis to promote inflammation
Kathryn Eby Beckermann, Rachel A. Hongo, Xiang Ye, Kirsten L. Young, Katie Carbonell, Diana C. Contreras, Peter J. Siska, Sierra M. Barone, Caroline E. Roe, Christof C. Smith et al. · 2020 · JCI Insight
Turning cold tumors into hot tumors to ignite immunotherapy
Yuan‐Tong Liu, Yunlong Wang, Shuo Wang, Jiajun Li, Wei A. He, Xin-Juan Fan, Xiang‐Bo Wan · 2025 · Molecular Cancer
Cell Programmed Nutrient Partitioning in the Tumor Microenvironment
Bradley I. Reinfeld, Matthew Z. Madden, MM Wolf, Anna M. Chytil, Jackie E. Bader, Andrew R. Patterson, AS Cohen, Alaa Kassim Ali, Brian T. Do, Alexander Muir et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
Is Lactate an Oncometabolite? Evidence Supporting a Role for Lactate in the Regulation of Transcriptional Activity of Cancer-Related Genes in MCF7 Breast Cancer Cells
Iñigo San-Millán, Colleen Glyde Julian, Christopher J. Matarazzo, Janel L. Martinez, George A. Brooks · 2020 · Frontiers in Oncology
Metabolomics, metabolic flux analysis and cancer pharmacology
Lingfan Liang, Fei Sun, Hongbo Wang, Zeping Hu · 2021 · Pharmacology & Therapeutics
Glutamine addiction in tumor cell: oncogene regulation and clinical treatment
Xian Li, Xueqiang Peng, Yan Li, Shibo Wei, Guangpeng He, Jiaxing Liu, Xinyu Li, Shuo Yang, Li Dai, Weikai Lin et al. · 2024 · Cell Communication and Signaling
Nutrients: Signal 4 in T cell immunity
Jana L. Raynor, Hongbo Chi · 2024 · The Journal of Experimental Medicine
Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment
Yu-Heng Zhu, Jia-Hao Zheng, Qin-Yuan Jia, Zong‐Hao Duan, Hong‐Fei Yao, Jian Yang, Yongwei Sun, Shu-Heng Jiang, Dejun Liu, Yan‐Miao Huo · 2022 · Cellular Oncology
Hyaluronic acid fuels pancreatic cancer cell growth
Kim, Peter K, Halbrook, Christopher J, Kerk, Samuel A, Radyk, Megan, Wisner, Stephanie, Kremer, Daniel M, Sajjakulnukit, Peter, Andren, Anthony, Hou, Sean W, Trivedi, Ayush et al. · 2021 · eLife
Nanomaterial-enabled metabolic reprogramming strategies for boosting antitumor immunity
Mengdi Ma, Yongliang Zhang, Kanyi Pu, Wei Tang · 2024 · Chemical Society Reviews
Strategies to enhance CAR-T persistence
Liu, Yue, An, Lingna, Huang, Ruihao, Xiong, Jingkang, Yang, Haoyu, Wang, Xiaoqi, Zhang, Xi · 2022 · Biomarker Research
1-Methylnicotinamide is an immune regulatory metabolite in human ovarian cancer
Marisa K. Kilgour, Sarah MacPherson, Lauren G. Zacharias, Abigail E. Ellis, Ryan D. Sheldon, Elaine Y. Liu, Sarah Keyes, Brenna Pauly, Gillian A. Carleton, Bertrand Allard et al. · 2021 · Science Advances
A high OXPHOS CD8 T cell subset is predictive of immunotherapy resistance in melanoma patients
Chuan Li, Yee Peng Phoon, Keaton S. Karlinsey, Ye F. Tian, Samjhana Thapaliya, Angkana Thongkum, Lili Qu, Alyssa Matz, Mark J. Cameron, Cheryl Cameron et al. · 2021 · The Journal of Experimental Medicine
Advancing Cancer Treatment by Targeting Glutamine Metabolism—A Roadmap
Anna Halama, Karsten Suhre · 2022 · Cancers
Glutamine and cancer: metabolism, immune microenvironment, and therapeutic targets
Ding Nan, Weiping Yao, Luanluan Huang, Ruiqi Liu, Xiaoyan Chen, Wenjie Xia, Hailong Sheng, Haibo Zhang, Xiaodong Liang, Yanwei Lü · 2025 · Cell Communication and Signaling
Cellular senescence and metabolic reprogramming: Unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment
Fusheng Zhang, Junchen Guo, Shengmiao Yu, Youwei Zheng, Meiqi Duan, Liang Zhao, Yihan Wang, Zhi Yang, Xiaofeng Jiang · 2024 · 癌症：英文版
Glutaminases regulate glutathione and oxidative stress in cancer
Matés, José M., Campos-Sandoval, José A., de los Santos-Jiménez, Juan, Márquez, Javier · 2020 · Archives of Toxicology
Limited nutrient availability in the tumor microenvironment renders pancreatic tumors sensitive to allosteric IDH1 inhibitors
Ali Vaziri Gohar, Joel A. Cassel, Farheen S. Mohammed, Mehrdad Zarei, Jonathan J. Hue, Omid Hajihassani, Hallie J. Graor, Yellamelli V. V. Srikanth, Saadia A. Karim, Ata Abbas et al. · 2022 · Nature Cancer
LncRNAs in tumor metabolic reprogramming and immune microenvironment remodeling
Jiecheng Yang, Fangzhou Liu, Ying Wang, Lei Qu, Aifu Lin · 2022 · Cancer Letters
SLC1A5 enhances malignant phenotypes through modulating ferroptosis status and immune microenvironment in glioma
Liying Han, Jinpeng Zhou, Leiyang Li, Xun Wu, Yingwu Shi, Wenxing Cui, Shenghao Zhang, Qing Hu, Jin Wang, Hao Bai et al. · 2022 · Cell Death and Disease
Noncoding RNAs link metabolic reprogramming to immune microenvironment in cancers
Yiyin Zhang, Qijiang Mao, Qiming Xia, Jiaxi Cheng, Zhengze Huang, Yirun Li, Peng Chen, Jing Yang, Xiaoxiao Fan, Yuelong Liang et al. · 2021 · Journal of Hematology & Oncology
Fueling T-cell Antitumor Immunity: Amino Acid Metabolism Revisited
Chenfeng Han, Minmin Ge, Ping‐Chih Ho, Lianjun Zhang · 2021 · Cancer Immunology Research
Amino acid metabolism reprogramming: shedding new light on T cell anti-tumor immunity
Yue Zheng, Yiran Yao, Tongxin Ge, Shengfang Ge, Renbing Jia, Xin Song, Ai Zhuang · 2023 · Journal of Experimental & Clinical Cancer Research
The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells
Jiangping Li, Zhiwen Xiao, Donghui Wang, Lei Jia, Shihong Nie, Xingda Zeng, Wei Hu · 2023 · Molecular Cancer
From thymus to tissues and tumors: A review of T-cell biology
Laura B. Chopp, Christopher Redmond, John J. O’Shea, Daniella M. Schwartz · 2022 · Journal of Allergy and Clinical Immunology
Metabolic pathway analysis using stable isotopes in patients with cancer
Caroline Bartman, Brandon Faubert, Joshua D. Rabinowitz, Ralph J. DeBerardinis · 2023 · Nature reviews. Cancer
Advances in metabolic reprogramming of NK cells in the tumor microenvironment on the impact of NK therapy
Linxuan Miao, Chenglin Lu, Bin Zhang, Huili Li, Xu Zhao, Haoran Chen, Ying Liu, Xiaonan Cui · 2024 · Journal of Translational Medicine
Differential integrated stress response and asparagine production drive symbiosis and therapy resistance of pancreatic adenocarcinoma cells
Halbrook, Christopher J., Thurston, Galloway, Boyer, Seth, Anaraki, Cecily, Jiménez, Jennifer A., McCarthy, Amy, Steele, Nina G., Kerk, Samuel A., Hong, Hanna S., Lin, Lin et al. · 2022 · Nature Cancer
Inhibition of UBA6 by inosine augments tumour immunogenicity and responses
2022
Tumor microenvironment and metabolic remodeling in gemcitabine‐based chemoresistance of pancreatic cancer
Zongting Gu, Yongxing Du, Xueping Zhao, Chengfeng Wang · 2021 · Cancer Letters
Glutamine mimicry suppresses tumor progression through asparagine metabolism in pancreatic ductal adenocarcinoma
Maria Victoria Recouvreux, Shea F. Grenier, Yijuan Zhang, Edgar Esparza, Guillem Lambies, Cheska Marie Galapate, Swetha Maganti, Karen Duong‐Polk, Deepika Bhullar, Razia F. Naeem et al. · 2023 · Nature Cancer
Metabolic regulation of immunity in the tumor microenvironment
Shen Li, Yu Zhang, Huan Tong, Haozhen Sun, Hu Liao, Qingfang Li, Xuelei Ma · 2025 · Cell Reports
Exercise and immunometabolic regulation in cancer
Graeme J. Koelwyn, Xueqian Zhuang, Tuomas Tammela, Andrea Schietinger, Lee W. Jones · 2020 · Nature Metabolism
Targeting Glutamine Metabolism to Enhance Immunoprevention of EGFR‐Driven Lung Cancer
Mofei Huang, Donghai Xiong, Jing Pan, Qi Zhang, Shizuko Sei, Robert H. Shoemaker, Ronald A. Lubet, Luis M. Montuenga, Yian Wang, Barbara Stauch Slusher et al. · 2022 · Advanced Science
A Cholesterol Metabolic Regulated Hydrogen‐Bonded Organic Framework (HOF)‐Based Biotuner for Antibody Non‐Dependent Immunotherapy Tailored for Glioblastoma
Na Yin, Yinghui Wang, Yang Liu, Rui Niu, Shuai Zhang, Yue Cao, Zhijia Lv, Shuyan Song, Xiaogang Liu, Hongjie Zhang · 2023 · Advanced Materials
Modulation of macrophage metabolism as an emerging immunotherapy strategy for cancer
Corey Dussold, Kaylee Zilinger, Jillyn R Turunen, Amy B. Heimberger, Jason M. Miska · 2024 · Journal of Clinical Investigation